CLONAL CHARACTER OF F1 HYBRID LYMPHOCYTE SUBSET RECOGNITION OF PARENTAL CELLS IN ONE-WAY MIXED LYMPHOCYTE CULTURES by Gebhardt, Bryan M. et al.
CLONAL  CHARACTER  OF  FI  HYBRID  LYMPHOCYTE  SUBSET 
RECOGNITION OF  PARENTAL  CELLS  IN  ONE-WAY  MIXED 
LYMPHOCYTE  CULTURES*, :~ 
BY BRYAN  M.  GEBHARDT,  YOSHINOBU NAKAO,§ aND RICHARD T.  SMITH 
(From the Tumor Biology  Unit, Department of Pathology,  University of Florida College 
of Medicine, Gainesville,  Florida 32610) 
(Received  for publication 8 April 1974) 
F1 hybrid lymphoid cells proliferate in vitro in one-way mixed lymphocyte 
cultures  (MLC) 1 with  nonproliferating  parental  target  cells  (1-3).  This  ob- 
servation has been confirmed in some systems (3), but not all (4, 5). The  effec- 
tiveness of this  apparent  cellular  immunocompetence is  limited,  however.  F1 
hybrid mice fail to reject grafts of parental tissue and do not react  detectably 
to their parents in graft-vs.-host experiments. Transplanted parental  tissue  is 
not ignored in all situations.  For example, tumors of parental origin grow more 
slowly in  Fx recipients  than  in  the  parental  strain  (6,  7).  Irradiated  Fx mice 
resist parental bone marrow grafts (8, 9). F1 hybrid rats injected with parental 
lymphoid cells produce serum antibodies specific for parental recognition struc- 
tures  (10).  F1 hybrid mice given repeated injections of parental cells are more 
resistant to induction to GVH with parental cells than uninjected animals (11). 
It seemed  appropriate  from  these  considerations  to  seek further  evidence of 
specific recognition responses as the basis for the observed in vitro responses of 
F1 toward parental cells. 
The  studies  to  be described  define  F1  hybrid  cell  proliferation induced  by 
parental  cells  in  vitro  in  terms  of proliferating  clonal  F1  cell  subsets  which 
appear to respond independently to parental structures controlled by genes in 
or linked to the major histocompatibility locus (MHC) of the mouse. 
Materials and Methods 
Animals.--A/J,  C57BL/6, CBA/J,  Balb/c,  DBAC/2,  C57BL/10(B10), C57BL/10-BR 
(B10.BR),  C57BL/10-D2(B10.2),  C57BL/10-A(B10-A),  and  various F1 hybrids derived 
from matings of these inbred strains were obtained either directly from Jackson Laborato- 
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ries, Bar Harbor,  Maine or derived from inbred lines  maintained in this laboratory  origi- 
nating from Jackson stocks. In all experiments female Fz ceils were tested with female par- 
ental ceils in MLC and all cells were taken from age-matched sources. 
Induction  and Maintenance of Tumors.--Fibrosarcomas  were produced and maintained by 
techniques and procedures described in detail elsewhere (12, 13). 
Preparation  of Lymphoid  Cell Suspension.--Thymus or spleen cells were  taken after ex- 
sanguination via the abdominal aorta. As described previously  (14),  special care was taken 
to exclude lymph nodes adjacent to the thymus. Cell suspensions were prepared by gently 
pressing small  tissue fragments suspended  in  RPMI-1640  culture  medium  (Grand  Island 
Biological Co., Grand Island, N. Y.)  through 60-mesh stainless steel screens and passing the 
resultant suspension through 23- and 27-gauge needles. 
Cell Culture System.--A  modification of  methods previously  reported  (13-15)  was  em- 
ployed in which mixtures of 1 X  106 responding ceils and an equal number of target cells were 
cultured in 0.5-ml vol of medium  (94% RPMI, 5% fresh human serum, and 1% penicillin- 
streptomycin) in  12  X  75-mm sterile plastic tubes  (no. 2063, Falcon Plastics, Div. of Bio- 
Quest, Oxnard, Calif.). DNA synthesis in the target cells was blocked by incubating 15 X  106 
cells with 0.1-ml mitomycin C  (Nutritional Biochemicais Corporation, Cleveland, Ohio) at a 
concentration of 50/zg/ml. After 40 min of incubation at 37°C, the blocked cells were washed 
three times and recounted before addition to the culture tubes. All cultures were incubated 
for 96-120 h  at 37°C  in a  humidified 5% COs-air environment. 1  day  before  the  cultures 
were  terminated,  0.5  /zl  of  tritiated  thymidine  (sp act  1.9  Ci/mM,  Schwarz/Mann  Div., 
Becton, Dickinson & Co., Orangeburg, N. Y.) was added to each culture. After the final 24 h 
of incubation, all cultures were washed once with 4-ml saline, 4-ml cold 5% TCA, and 4-ml 
cold absolute methanol. After the methanol wash,  the tubes were inverted, allowed to dry 
thoroughly, and the TCA precipitates solubilized in 0.1 ml of NCS solubilizer (Amersham/ 
Searle Corp., Chicago, Ill.). The solubilized material was transferred to scintillation vials by 
rinsing the culture tubes with two 2.5-ml rinses of scintillation fluid. All vials were counted in 
a  Beckman  LS-250  liquid  scintillation  counter  (Beckman  Instrumetnts,  Inc.,  Fullerton, 
Calif.).  Cultures were set up in  quadruplicate, and the results are reported as the mean ± 
standard error for each group of four. 
Clone Elimination  ProtocoL--Experiments  involving attempts to eliminate reactive  clones 
represent modification of the protocol described by Zoschke and Bach (16). 48 h  after MLC 
were initiated, 5-bromodeoxyuridine  (BUdR)  at a  final concentration of 5  X  10  -5 M  was 
added  to each culture.  The cultures were reincubated at 37°C  for an additional 12 h,  and 
exposed to light by positioning the culture tube rack over a  fluorescent lamp such that the 
bottom of the tubes were 5 cm from the tube. After a 60-min exposure, the cells in each tube 
were washed once and resuspended in 0.5-ml fresh culture medium. This procedure was shown 
to eliminate proliferating cells in allogeneic systems, as previously described (16). At this time, 
a  second mitomycin-blocked target cell population was added. Control cultures included re- 
addition of the same target cell population present during the first 36 h, ceils from  the other 
parent third-party (allogeneic) target cells,  or no added target cells.  All cultures were reincu- 
bated for an additional 72 h; [3H]TdR was added during the final 24 h after which the cultures 
were terminated and prepared for scintillation counting as outlined above. 
Chromosome Analysis  of Proliferating Cells in MLC.--Spleen  or lymph node cells taken 
from mice of  the CBA/H-T6J  and  (CBA/CaJ  X  C57BL/6)Fz strains were used in MLC. 
[3H]TdR was added at the prescribed 72-h time period. 4 hours before the cultures were to be 
harvested for scintillation counting, 0.04 ml of colcemide was added to each. At the time of 
harvesting, 0.1-ml aliquots of each cell culture were collected and individually prepared for 
chromosome analysis according to the procedures of Moorehead et al.  (17). The remaining 
0.4  ml of cultured cells were prepared for scintillation counting. The microscopic slides of 
colcemide-treated cells were stained with Giemsas and systematically examined for metaphase 
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the T6 marker noted. None of over 6,000 metaphase plates examined from one-way MLC 
between (C57BL/6 X  CBA/CaJ)Fi  and mitomycin-treated parent CBA/H-T6J contained 
the T6 marker. 
RESULTS 
F1  Hybrid Stimulation by  Parental Spleen Cells in  One-Way MLC.--The 
original observation in which F1 spleen cells were stimulated by parental cells 
(1) has been extended to Fi hybrid combinations of available congenic lines on 
the  C57BL/10 background.  Representative data  are  given in Table  I.  Each 
combination shown is representative of data obtained from at least five identi- 
cal experiments. These experiments extend the previously reported results (1) 
to multiple combinations; each FI shows significant DNA synthesis in response 
to parental  cells.  These observations may be interpreted to indicate that  F1 
hybrid  proliferation,  in  the  presence  of  mitornycin-blocked  parental  cells, 
signifies stimulation by parental cell structures controlled by genes in or linked 
closely with the MHC chromosome region of the mouse. 
Alternative  interpretations  of  this  basic  observation  have  been  explored 
extensively. It was first important to establish that proliferation in MLC was 
limited to F1 cells. This was approached in two ways. First by including mito- 
mycin-treated  target  cells  alone  as  controls in  each  experiment and  finding 
that these do not proliferate (see Table I).  Secondly by examining MLC be- 
tween  F1 hybrids resulting  from matings  between  CBA/HeT6T6 with  other 
strains and determining whether the F1 or parental cell population proliferates. 
Table II illustrates the results of six experiments and confirms that proliferation 
is limited to the Fi hybrid cells. Blocking efficacy has been further established 
by extensive dose-effectiveness studies  of  the  mitomycin-blocking technique 
employed, as illustrated in Table III. 
A  second alternative  interpretation  is  that  the  blocked parental  cells are 
stimulated by allogeneic histocompatibility structures in the F~ cell membrane 
and secrete a  "blastogenic" factor which  thereupon triggers F1 proliferation. 
This mechanism would not depend upon DNA synthesis in the parental cell as 
a  preamble  to secretion, and  the proliferation initiated would be nonspecific 
to the F1 hybrid. Such factors have been reported in several in vitro systems 
(18-22).  Target cells in  MLC  also  release alloantigens  into  the  supernatant 
fluid of MLC,  but  the power of such fluids  to  stimulate  was  specific to  the 
alloantigen  (23).  This possible  explanation was  examined directly in  experi- 
ments in which supernates from one-way Fi-parental interaction in MLC were 
added to syngeneic F~ cells (Table IV) but without detectable mitogenic effect. 
Within the limitations of experimental design, such experiments, together with 
data to be reported below, appear to rule out a secreted nonspecific blastogenic 
factor but do not exclude the possibility of a close range ceil-to-cell blastogenic 
effect. 
A third possible alternative is that F~ hybrid response is a result of expression 
of recessive genes governing recognition. The F~ parental combinations within 
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TABLE  I 
Proliferation  of Fx Hybrid Spleen  Cells in One-Way MLC with Target Cells of Parental  Origin* 
F1 hybrid  Mitomycin-blocked  [aHlThyrnidine 
target cell  incorporation 
(A/J ×  C57BL/6J) 
(A/J X  C57BL/6J) 
(A/J X  C57BL/6J) 
(A/J X  C57BL/6J) 
(BALB/cJ X  A/J) 
(BALB/cJ X  A/J) 
(BALB/cJ X  A/J) 
(BALB/cJ X  A/J) 
(C3H/HeJ  X  DBA/2J) 
(C3H/HeJ  X  DBA/2J) 
(C3H/HeJ  X  DBA/2J) 
(C3H/HeJ X  DBA/2J) 
(C57BL/6J X  CBA/J) 
(C57BL/6J X  CBA/J) 
(C57BL/6J  X  CBA/J) 
(C57BL/6J X  CBA/J) 
(C57B10 X  C57B10.A) 
(C57B10)< C57B10.A) 
(C57B10 X  C57B10.A) 
(C57B10 X  C57B10.A) 
(C57B10-BR X  C57B10.A) 
(C57B10-BR >( C57B10.A) 
(C57B10.BR X  C57B10.A) 
(C57B10.BR  X  C57B10.A) 
(C57B10.BR  X  C57B10) 
(C57B10.BR)<  C57B10) 
(C57B10.BR X  C57B10) 
(C57B10.BR  X  C57B10) 
mean cpm "4- SE 
--  1,354  -4-  326 
(A/J X  C57BL/6J)  1,733  4-  288 
A/J  7,263  4-  142 
C57BL/6J  9,077  4-  204 
A/J  38  .4-  9 
C57BL/6J  51  .4-  14 
--  846  .4-  51 
(BALB/cJ X  A/J)  1,686  .4-  133 
BALB/cJ  3,927  .4-  262 
A/J  2,589  +  101 
BALB/cJ  89  .4-  12 
A/J  47  -4-  4 
--  502  q-  157 
(C3H/HeJ  X  DBA/2J)  926  -4-  75 
C3H/HeJ  3,725  -4-  299 
DBA/2J  4,137  q-  654 
C3H/HeJ  24  4-  6 
DBA/2J  75  4-  23 
--  217  4-  44 
(C57BL/6J X  CBA/J)  890  -4-  72 
C57BL/6J  5,422  4-  319 
CBA/J  4,203  4-  512 
C57BL/6J  97  q-  4 
CBA/J  83  4-  12 
--  1,206  4-  427 
(C57B10 X  C57B10.A)  1,640  -4-  145 
C57B10  4,930  -4-  650 
C77B10.A  3,554  -4-  210 
C57B10  49  .4-  10 
C57B10.A  93  4-  7 
--  2,338  4-  94 
(C57B10-BR X  C57B10.A)  3,183  4-  138 
C57B10-BR  3,274  4-  275 
C57B10.A  3,576  +  353 
C57B10.BR  91  4-  9 
C57B10.A  75  4-  2 
--  2,610  -4-  853 
(C57B10.BR  X  C57B10)  5,640  4-  1,580 
C57B10.BR  4,280  q-  637 
C57B10  7,401  4-  719 
C57B10.BR  124  .4-  24 
C57B10  65  4-  5 
* 1 X  106 Ft spleen cells were  cocultured with an equal number of  mitomycin-blocked 
target cells in 0.5 ml of culture medium. [SH]thymidine was added at 72 h  and the cultures 
were  terminated at 96 h. The data are presented as mean values  .4-  SE for four replicate 
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TABLE  II 
T6 Chromosomes in Cells Comprising  Fi Hybrid Parent MLC's* 
Number of  Number of 
metaphases  metaphases  [,HlThymidine 
F1 hybrid  Target cell~  without T6  with T6  chro  -  chro-  incorporation 
mosomes  mosomes 
mean epm 4- SE 
(CBA/CaJ X C57BL/6)FI  --  0  0  305  :h 54 
(CBA/CaJ X C57BL/6)FI  (CBA/CaJ  X C57BL/6)Fl[M]  0  0  295  =h 62 
(CBA/CaJ X C57BL/6)F1  CBA/H-T6J[MI  140  0  2,416 :k 341 
--  CBA/H-T6J[M]  0  0  93  4- 8 
(CBA/CaJ X C57BL/6)F1  CBA/H-T6J  102  129  75,511 =h 3,059 
* 1 X 10 s F1 spleen ceils were cocultured with an equal number of mitomycin-blocked target cells in 0.5 ml 
of culture medium. [3H]thyrnidlne  was added at 72 h, colcemide at 92 h, and the cultures were terminated at 96 
h. The data are presented as mean values A: SE for four replicate tubes; the chromosomal  data represent examina- 
tion of over 1,000 morphologically  intact metaphase plates. 
:~ Target  cells with the suffix [M] were mitomycin blocked. Mitomycin-blocked ceils alone had [3H]TdR 
incorporation values of less than 100 cpm. 
TABLE  III 
Effectiveness  of Blocking  of DNA  Synthesis  in  Spleen  Cdls  Treated  with  Varying  Amounts 
of Mitomycin C* 
Cell combination tested in MLC 
Concentration of 
mitomycin (~g)  [3H]Thymidine 
used to treat 
C57BL/6J target  incorporation 
spleen cells 
mean cpm ::h SE 
(C57BL/6J  X  CBA/J)  +  C57BL/6J  0  59,424  "4-  2,019 
(C57BL/6J  ×  CBA/J)  +  C57BL/6J[M]  10  14,511  -4-  832 
(C57BL/6J  X  CBA/J)  +  C57BL/6J[M]  25  2,340  -4-  212 
(C57BL/6J  ×  CBA/J)  +  C57BL/6J[M]  50  3,172  -4-  198 
(C57BL/6J  X  CBA/J)  +  C57BL/6J[M]  100  2,754  -4-  72 
(C57BL/6J  X  CBA/J)  +  C57BL/6J]Ml  200  2,097  -4-  215 
C57BL/6J  0  539  -4-  22 
C57BL/6J[M]  10  290  ±  74 
C57BL/6J[M]  25  117  ±  18 
C57BL/6J[M]  50  33  -4-  4 
C57BL/6J[Ml  100  56  "4-  7 
C57BL/6J[M]  200  47  +  9 
C57BL/6J  +  PHA(0, 25 #1)  0  90,644  -4-  8,743 
C57BL/6J[M]  +  PHA(0, 25 #1)  10  7,140  -4-  1,229 
C57BL/6J[M]  +  PHA(0, 25 #1)  25  867  -4-  256 
C57BL/6J[M]  +  PHA(0, 25 #1)  50  153  -4-  35 
C57BL/6J[M]  +  PHA(0, 25 #1)  100  78  -4-  11 
C57BL/6x[M]  -t- PHA(0, 25 ~1)  200  116  -4-  29 
* Cultures containing 1 X  106 spleen cells were taken from a pool of 30 X  106 cells which 
had been incubated for 30 rain at 37°C with the indicated amount of mitomycin C in 0.5 ml 
of eulture medium and washed three times. These were incubated as target cells with 1  X 
106 Fi hybrid cells, alone, or with PHA (0, 25 #1) as indicated for 72 h. [3H]TdR was added 
for the final 24 h. The data are mean values -4- SE of four replicate tubes. BRYAN  M.  GEBHARDT,  ¥OSHINOBU  NAKAO~  RICHARD  T.  SMITH  375 
TABLE IV 
Effect of Fi Hybrid-Parental Culture Supernatant Fluids upon  Syngeneic F1 Hybrid  Spleen Cells* 
Volume  [aH]Thymidine 
Source of culture supernate  supernate  FI hybrid test cell  incorporation 
tested 
tzl  mean cpm 4- SE 
(A/J X C57BL/6J)  q- A/Jm  --  (n/J X C57BL/J)  371  4-  78 
(A/J X C57BL/6J)  q- A/Jm  10  (A/J X C57BL/J)  239  4-  44 
(A/J X C57BL/6J)  q- A/Jm  50  (A/J X C57BL/J)  416 4-  70 
(A/J X C57BL/6J)  -[- A/Jm  100  (A/J X C57BL/J)  390  4-  87 
(A/J X C57BL/6J)  q- A/Jm  250  (A/J X C57BL/J)  113  4-  17 
(A/J X C57BL/6J)  q- A/Jm  500  (A/J X C57BL/J)  201  4-  49 
(C57BL/6 X DBA/2J)  q- DBAm  --  (C57BL/6J X DBA/2J)  535  4-  93 
(C57BL/6 X DBA/2J)  q- DBAm  10  (C57BL/6J X DBA/2J)  416  4-  35 
(C57BL/6 X DBA/2J)  q- DBAm  50  (C57BL/6J X DBA/2J)  690  -4- 83 
(C57BL/6 X DBA/2J)  q- DBAm  100  (C57BL/6J)<  DBA/2J)  612  4-  21 
(C57BL/6 X DBA/2J)  q- DBAm  250  (C57BL/6J X DBA/2J)  552  4-  66 
(C57BL/6 X DBA/2J)  -b DBAm  500  (C57BL/6J X DBA/2J)  627  -4- 60 
* In these experiments the  culture  supernates  from various Fi parent one-way MLC 
were added to cultures of syngeneic Fi hybrid cells in the volumes indicated. The indicator 
cultures were then incubated 72 h; the final 24 h in the presence of [3H]TdR. 
These data,  together with those to be described,  render it quite unlikely that 
recessive gene expression is the explanation of the observed phenomena. 
Augmentation  of  F1-Parental  MLC  by  Tumor-Bearing  Mice.--Inbred  and 
congenic mice bearing methylcholanthrene (MCA)-induced fibrosarcomas (12, 
13)  or after treatment with  BCG  (24)  have expanded T- and  B-lymphocyte 
subpopulations  and  a  greatly  augmented  capacity  to  express  primary  allo- 
antigen  recognition in MLC.  It was of interest,  therefore,  to examine tumor- 
bearing F1 congenic mice for analogous augmentation of alloantigen recognition. 
(B10. BR )<  B10)F1 mice bearing MCA tumors developed in that combination 
were  assessed for their  responsiveness to parental  spleen  cells. The  resultant 
data are illustrated by the experiment shown in Fig. 1. The dose-response rela- 
tionship between responding F1 and target-parental cells indicated significantly 
elevated levels of responsiveness to parent in the tumor-bearing animals. These 
data provide further  evidence that  F1  recognition  responses  toward parental 
antigens are similar to those between allogeneic cells in the same system. 
Evidence for Separate  Parental  Recognition  Subsets  in F1 Itybrids.--Several 
types of evidence indicate that proliferative responses to alloantigens in MLC 
are clonal with respect to subsets of responding cells (25-28). Two experimental 
approaches were made to detect separate subsets of recognition cells in the F1 
hybrid responsive for each set of parental alloantigens. The first depended upon 
the prediction  that  such  subsets should  respond independently  and  therefore 
additively  in  one-way  MLC.  This  appears  to  be  the  case,  as  illustrated  in 
Table V.  Responses to parental  cells at peak target to responding cell ratios 376  F1  HYBRID RECOGNITION  OF  PARENT  IN  MIXED  CULTURE 
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FIG. 1.  Dose-response relationship of normal and tumor-bearing F1 hybrid recognition of 
parent in  one-way mixed culture.  Spleen cells  from normal  (N)  and  tumor-bearing  (TB) 
(B10.BR  X  B10)F1  mice were  tested for reactivity to  several concentrations of blocked 
parental or alloantigenic cells  (B10.D2).  The  values given represent means and  standard 
errors of four replicate cultures. 
TABLE  V 
Effect of Mixtures of Both Parental Cells as Ttlrget Cells on Proliferation in MLC* 
Ratio 
F1 hybrid  Target cell~  of reacting  [3H]Thymidine 
cells to  incorporation 
target cells 
mean cpm -4- SE 
(C57BL/6J X  CBA/J)  --  --  210  -4-  8 
(C57BL/6J  X  CBA/J)  (C57BL/6J  X  CBA/J)[M]  1:0.5  297  ±  62 
(C57BL/6J  X  CBA/J)  (C57BL/6J  X  CBA/J)[M]  1:1  771  -4-  38 
(C57BL/6J  X  CBA/J)  CBA/J[M]  1:0.5  2,300  -4-  124 
(C57BL/6J X  CBA/J)  CBA/J[M]  1 : 1  2,577  ±  322 
(C57BL/6J  X  CBA/J)  C57BL/6J[M]  1:0.5  2,100  -4-  208 
(C57BL/6J  X  CBA/J)  C57BL/6J[M]  1:1  1,853  ±  431 
(C57BL/6J ×  CBA/J)  C57BL/6J[M]  +  CBA/J[M]  1:0.5  2,407  ±  194 
(C57BL/6J X  CBA/J)  C57BL/6J[M]  +  CBA/J[M]  1:1  5,516  ±  411 
* 1 X  106 Fz spleen cells were cultured with 0.5  X  106 or 1 X  106 mitomycin-blocked 
cells from one of the parents or with equivalent aliquots from both parents. The final culture 
vol was 0.5 ml in all instances. [aH]TdR  was added at 72 h and the cultures were terminated 
at 96 h. The data are given for four replicate tubes. 
Mitomycin-blocked cells alone always gave [3H]TdR  incorporation values  of less than 
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were indeed additive when both were added to F1 responding ceils in five such 
experiments involving three-strain combinations. 
The second approach was to eliminate proliferating F1 cells in MLC contain- 
ing one parent through treatment with BUdR and light as described by Zoschke 
and Bach  (16)  and  then test for residual  responsiveness to the  other parent. 
Table VI gives the results of representative experiments of this type involving 
different strain combinations. Elimination of the proliferating population stimu- 
lated  by one parent failed reciprocally to  affect responsiveness to  the other, 
while readdition of the same parental cells resulted in no F1 proliferation. The 
demonstrated  adequacy  of  the  rnitomycin  block  of parental  cells  precludes 
allogeneic interactions between  these  cells.  Dose-response  titrations  were in- 
cluded to eliminate the possibility of inhibitory target-responding cell  ratios. 
These data may be interpreted to substantiate the hypothesis that F1 prolifera- 
tion in the presence of each parent is clonal; that is, generated in individual sub- 
sets of lymphoid  cells,. Moreover the data effectively rule out  several of the 
alternatives  considered.  For  example,  the  effects  of  nonspecific  blastogenic 
factors  are  excluded since  such  factors  should  trigger  responses  in  both  re- 
sponding subsets rather than individually specific ones in sequence. Recessive 
gene expression also seems unlikely to be expressed in individual cell subsets. 
DISCUSSION 
Experiments reported here confirm and extend the basic observation that F, 
hybrid mouse lymphoid cells proliferate in MLC with blocked parental cells. 
Several  alternative  explanations  of  the  experimental  observations  were  ex- 
plored, including inadequacy of mitomycin C  block of target cells,  the possi- 
bility  that  nonspecific  blastogenic  factors  produced  by  the  blocked  parent 
induce proliferation in  the  F1,  and  that  recessive gene  expression might  be 
involved. No direct experimental support was found for any of these alternative 
interpretations. The data do not rigorously exclude that blocked parental cells 
might initiate F1 proliferation as a result of recognition responses on their own 
part.  If true, this recognition response must occur in cells incapable of DNA 
synthesis  and  somehow be communicated directly and  specifically as  a  pro- 
liferation inducing stimulus to an unblocked nonrecognizing F1 cell. In view of 
the apparently clonal nature of the FI response it  would  additionally  require 
that  the  antigenic sites of the  recognized structure on the  F1 hybrid cell be 
clonally represented as well. While conceivable, this possibility has no experi- 
mental  support  at present.  On  the  other hand,  direct evidence is  presented 
indicating that F1 is in recognition of parent, is clonal, and involves separate 
subsets  of  responding  cells  having  specificity  directed  toward  each  parent. 
Moreover the F1-parent MLC appears in every way tested to be analogous to 
MLC reactions between allogeneic cells. 
Interpreted in this way, consideration must be given (a) to the characteristics 
of and control over the recognition process and the responding cell subsets and 378  FI  HYBRID  RECOGNITION  OF  PARENT  IN  MIXED  CULTURE 
TABLE  VI 
Clonal Character of F1 Hybrid Subsets Stimulated  by Parental Cells in One-Way MLC* 
[~H]Thymidine  FI hydrid  First target cells added  Second target cells added  incorporation 
mean cpra -4- SE 
(C57BL/6J X  CBA/J)  --  --  376 q- 42 
(C57BL/6J X  CBA/J)  (C57BL/6J X  CBA/J)  --  118  4- 11 
(C57BL/6J X  CBA/J)  --  (C57BL/6J X  CBA/J)  338  ±  71 
(C57BL/6J X  CBA/J)  (C57BL/6J X  CBA/J)  (C57BL/6J X  CBA/J)  210  -4-  18 
--  (C57BL/6J X  CBA/J)  --  31  4- 4 
--  --  (C57BL/6J 3<  CBA/J)  55  -4-  12 
--  (C57BL/6J X  CBA/J)  (C57BL/6J X  CBA/J)  72  4-  16 
(C57BL/6J X  CBA/J)  CBA/J  --  263  4- 20 
(C57BL/6J X  CBA/J)  --  CBA/J  1,094 4-  135 
(C57BL/6J X  CBA/J)  CBA/J  CBA/J  408  4- 74 
--  CBA/J  --  81  4- 14 
--  --  CBA/J  27  4- 5 
--  CBA/J  CBA/J  68  4-  17 
(C57BL/6J X  CBA/J)  C57BL/6J  --  435  4-  119 
(C57BL/6J X  CBA/J)  --  C57BL/6J  855  4- 76 
(C57BL/6J X  CBA/J)  C57BL/6J  C57BL/6J  215  4- 44 
--  C57BL/6J  --  97  4- 32 
--  --  C57BL/6J  45  4- 18 
--  C57BL/6J  C57BL/6J  87  4-  17 
(CSTBL/6J X  CBA/J)  CBA/J  C57BL/6J  3,025 4- 218 
(C57BL/6J X  CBA/J)  C57BL/6J  CBA/J  2,097 4-  109 
--  CBA/J  C57BL/6J  108  4- 9 
(A/J ×  C57BL/6J)  --  --  791  4- 55 
(A/J  X  C57BL/6J)  (A/J  X  C57BL/6J)  --  524 4- 91 
(A/J X  C57BL/6J)  --  (A/J X  C57BL/6J)  454  4- 65 
(A/J X  C57BL/6J)  (A/J)<  C57BL/6J)  (A/J X  C57BL/6J)  431  4- 63 
--  (A/J X  C57BL/6J)  --  77  4- 22 
--  --  (A/J X  C57BL/6J)  34 4- 5 
--  (A/J  X  C57BL/6J)  (A/J X  C57BL/6J)  80  4-  16 
(A/J X  C57BL/6J)  A/J  --  325  4- 87 
(A/J X  C57BL/6J)  --  A/J  976 4-  101 
(A/J  X  C57BL/6J)  A/J  A/J  612  4- 56 
--  A/J  --  75  4-  7 
--  --  A/J  -- 
--  A/J  A/J  48  4- 11 
(A/J X  C57BL/6J)  C57BL/6J  --  232  4- 87 
(A/J X  C57BL/6J)  --  C57BL/6J  704  4- 66 
(A/J  X  C57BL/6J)  C57BL/6J  C57BL/6J  316  4- 72 
--  C57BL/6J  --  95  4- 16 
--  --  C57BL/6J  89  4-  12 
--  CSlBL/6J  C57BL/6J  61  4- 18 
(A/J X  C57BL/6J)  A/J  C57BL/hJ  2,421  4- 203 
(A/J X  C57BL/6J)  C57BL/6J  A/J  2,970 4- 468 
--  A/J  C57BL/6J  84 4- 27 
(BALB/cJ X  A/J)  --  --  1,249 4-  114 
(BALB/cJ X  A/J)  (BALB/cJ X  A/J)  --  868  4- 35 
(BALB/cJ X  A/J)  --  (BALB/cJ X  A/J)  1,077  4-  151 
* 1 X  106 FI spleen cells were cultured with equal numbers of mitomycin-blocked target cells from one parent 
in 0.S-ml medium. The cultures were first incubated 48 h, then 5 X  10  -5 M BUdR was added for 12 h followed by 
exposure to light for one h and subsequently removal of the BUdR. 1.0 X  106 blocked ceils from  the second parent 
or the first parent again were added  to these cultures and they were reincubated for  an additional  48 h.  [~HI- 
thymidine was added at 96 h  and the cultures were terminated at 120  h.  The data  given are for four replicate 
tubes. BRYAN  M.  GEBHARDT,  YOSHINOBIY  NAKAO~  RICHARD  T.  SMITH 
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F1 hydrid  First target cells added  Second target  cells  added  (JH]Thymidine 
incorporation 
mean cpm 4- SE 
(BALB/cJ X  A/J)  (BALB/cJ X  A/J)  (BALB/cJ X  A/J)  650  4-  113 
--  (BALB/cJ X  A/J)  --  26  -4- 3 
--  --  (BALB/cJ X  A/J)  72  .4-  16 
--  (BALB/cJ X  A/J)  (BALB/cJ X  A/J)  99  -4-  14 
(BALB/cJ X  A/J)  BALB/cJ  --  '/02  -4-  125 
(BALB/cJ X  A/J)  --  BALB/cJ  1,633  4-  240 
(BALB/cJ X  A/J)  BALB/cJ  BALB/cJ  857  -4-  119 
--  BALB/cJ  --  63  4-  I0 
--  --  BALB/cJ  44  4- 20 
--  BALB/cJ  BALB/cJ  91  4-  13 
(BALB/cJ X  A/J)  A/J  --  4.53 4-  124 
(BALB/cJ X  A/J)  --  A/J  929  4- 57 
(BALB/cJ X  A/J)  A/J  A/J  846  4-  112 
--  A/J  --  57  4-  18 
--  --  A/J  93  4-  9 
--  A/J  A/J  71  4-  12 
(BALB/cJ X  A/J)  BALB/cJ  A/J  2,394 4- 308 
(BALB/cJ X  A/J)  A/J  BALB/cJ  2,841  4- 414 
--  BALB/cJ  A/J  117  4- 32 
(b) to the nature of the membrane structures to which the specificity of these 
subsets  is  directed. This interpretation implies further that  the proliferating 
clones represent self-recognition cell subsets. 
The F1 recognition subsets for parental cells have been characterized as widely 
represented in lymphoid tissues, including the immunologically competent sub- 
population of the  thymus. These characteristics,  taken  with  direct evidence 
that they carry the Thy-1 (0) membrane antigen, indicated that the responding 
cells belong to a subclass of T  cells not different from those which respond in 
allogeneic MLC. 
The existence of specific subsets of responding T cells for each set of parental 
cell  structures  indicates  that  the  recognition structures  are  not  necessarily 
codominantly expressed in the F~ hybrid, as is the case of membrane alloanti- 
gens. This provides a strong argument against the hypothesis that the phenome- 
non is explicable solely in  terms of allogeneic membrane nonconformity, the 
allogeneic stimulation hypothesis of Lafferty et al. (29). 
MLC reactions appear to involve at least two sequential elements. Initiation 
or permission is controlled by one set of gene loci termed lymphocyte defined 
(LD) in the mouse (30) or MLC in man (31). These loci are within or linked to 
the MHC, particularly in the Ir-lA gene region. It is not known whether the 
LD  locus  is  polymorphic or  whether  its  phenotype is  expressed  upon  the 
recognition or the target cell, or both, or at what level specificity is expressed. 
The second step,  cytotoxic cell generation, is thought  to depend upon  sero- 
logically defined structures on target cells determined by genes at the K  or D 
or 4 and LA regions of the MHC (30). While it is conceivable that both steps 380  FI  HYBRID  RECOGNITION  OF  PARENT  IN  MIXED  CULTURE 
are involved in Fl-parental MLC, the proliferation step is the only effect thus 
far demonstrated. Efforts are being made to test for cytotoxic cell generation. 
The structures on parental cells which appear to stimulate proliferation of the 
responsive T-cell subsets are not defined by these experiments except to limit 
them as determined by or linked to genes in the MHC locus. This provides a 
range of possibilities inherent in the expression of an estimated 1,000-2,000 loci 
gene  including  the  histocompatibility antigens  determined  serologically, LD 
locus products, idiotypic and other antigenic structures determined by the Ir 
loci, virus associated structures such as X-1  (Sato et al.) or Friend-Moloney- 
Rauscher viruses,  (32,  33) or even possibly expressions of S-tropic C-particle 
viruses incorporated into the genome in the IX linkage group (34). The data 
do not permit any precise conclusion as to which of these many structures might 
be involved. 
The experiments reported here and correlated with various types of evidence 
of in vivo responsiveness (8, 11) permit speculation that F1 hybrids and perhaps 
all heterozygotes carry clones of lymphoid cells capable of self-recognition and 
the immunologic consequences thereof. Although such a self-responding system 
is probably controlled or moderated in vivo through some mechanism  of self- 
tolerance, it may have a major role in repair and disposal of normal cells in so- 
called autoimmune disorders and in the process of oncogenesis. 
SUMMARY 
Proliferation  of  F1  hybrid  lymphocytes  in  mixed  lymphocyte cultures  is 
stimulated  by mitomycin-blocked parental  cells.  The  demonstration  of  this 
phenomenon using F1 hybrids derived from congenic lines of mice establishes 
that  the stimulation  is controlled by genes in or closely linked to the major 
histocompatibility locus  chromosome region.  In  agreement  with  the  finding 
that  tumor-bearing mice have an  increased capacity for primary alloantigen 
recognition, it  was  observed that  the  F1 hybrid response to parent was  also 
augmented by tumor bearing. 
Chromosomal analysis of dividing cells in one-way mixed cultures confirms 
that F1 cells, and not the blocked parental cells, enter mitosis. Stimulation of Fx 
cells by a soluble mediator liberated by the parental cells was not observed and 
mitomycin blocking of parental cells seems to be a completely effective block- 
ing agent ensuring that parental cells can not enter DNA synthesis. 
The specificity and  clonal nature  of F1  recognition of parent  was  demon- 
strated  using  a  5-bromodeoxyuridine-suicide procedure.  Distinct  clones  of 
lyraphocytes in F1 spleen cell populations seem to recognize one or the other 
parent, but not both, in such experiments. These observations and others in 
tumor systems suggest  that most or all heterozygous organisms may possess 
potentially self-reactive clones of lymphocytes. BRYAN  M.  GEBHARDT~  YOSHINOBU  NAKAO~  RICHARD  T.  SMITH  381 
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